Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It helps boost metabolism, support weight management, and improve cardiovascular health
Moving forward, the results of the phase 3 SURPASS clinical trial program demonstrated that tirzepatide was as effective and safe as other anti-diabetic agents, such as semaglutide and dulaglutide (SURPASS-2) (SURPASS J-mono), long-acting insulin analogs (degludec and glargine) (SURPASS-3,4), and placebo (SURPASS-1) (SURPASS-5), in managing T2DM diabetes [65,66,67,68,69]
What they did: n = 10 healthy volunteers (phototype IIIII)
The remaining products will ship within the standard shipping timeframe
US$ 20.06
US$ 21.53
US$ 25.27
